In 2014, Dyall et al. reported an array of pharmaceutical drugs with antiviral activity against MERS‐CoV, and SARS‐CoV‐1 (Table 2, chemical structure of all drugs were indicated in Figure S1). 121  The agents were grouped according to their modes of action. Hits inhibited both investigated CoVs.